News
-
Bango hits record revenue growth ahead of forecasts
Mobile payments technology business Bango saw its stock rise significantly when the UK market opened today after flagging up record revenue growth... Read More
-
Poles apart as Selvita plots €50m acquisition spree
A Polish company with Cambridge UK operations is seeking to acquire contract research organisations (CROs) after raising €20.6 million in new capital... Read More
-
Genetic key to fighting devastating bone cancer in children
Researchers at the Universities of East Anglia and Manchester have made a breakthrough that could lead to kinder treatments for children with bone... Read More
-
£2m for BAS space weather technology research
Space weather research at British Antarctic Survey in Cambridge has received a c£2 million funding boost from a major UK programme. SWIMMR is a £... Read More
-
Essex shares £5m to probe North Sea ‘rigs to reef’ dilemma
A team of University of Essex marine biologists is leading one of seven research projects sharing £5 million of funding to assess the impact of North... Read More
-
Strange but true as key hires help Closed Loop Medicine scale
Therapeutics company Closed Loop Medicine, whose UK registered office is at Babraham Research Campus, is scaling fast internationally on the back of... Read More
-
Cherie Blair and Cambridge Wireless step up digital drive for women entrepreneurs
Cambridge Wireless, the Cherie Blair Foundation for Women and Synergy Solutions are campaigning to help more female entrepreneurs in low and middle... Read More
-
Stansted Airport fights council’s “flawed planning refusal”
Stansted Airport has decided to appeal the decision made by Uttlesford District Council’s Planning Committee to refuse the airport’s application to... Read More
-
Avacta helps create COVID-19 hotspot detection in wastewater
An international consortium including Cambridge’s Avacta plc is developing and rolling out a wastewater detection system that represents a... Read More
-
Bit Bio deal gives BioMed Realty full house at Babraham flagship
US property powerhouse BioMed Realty has completed the lease-up of its landmark scheme at the Babraham Research Campus in Cambridge UK, underlining... Read More
-
£200m office development for Cambridge proposed
Mark Glatman's Abstract Securities reveals that its wholly owned subsidiary – Abstract (Cambridge) Limited – has exchanged contracts to acquire a 9.... Read More
-
Cranfield student in all-female crew heading to Mars research station
An all-female crew has secured funding to embark on a two-week mission to the Mars Desert Research Station in Utah in February 2021 and is looking to... Read More
-
Eric marks 100th birthday with online FuelTech lecture to Cranfield students
Fuel technology expert and former RAF World War II veteran Dr Eric Goodger, who once salvaged and repaired Spitfires, has found a novel way to mark... Read More
-
Companies start to feel crippling cash strictures, says BDO
Cash generation of businesses in East Anglia has stayed worryingly low heading into the financial crunch that’s starting to be triggered by the COVID... Read More
-
Cambridge trio helping refugee camps to contain COVID-19
Three PhD students from the Department of Engineering at Cambridge University have been awarded funding by Innovate UK to progress a software... Read More
-
Hewitsons acts in sale of Elogbooks to Marlowe Plc
The corporate team at Cambridge law firm Hewitsons represented the vendors in the sale of the St Ives based companies Elogbooks Facilities Management... Read More
-
Cambridge innovator backed to model future pandemics
Intellegens, an artificial intelligence spin out from the University of Cambridge, has won around £50k from Innovate UK to filter global COVID-19... Read More
-
Cambridge University role in ‘London after lockdown’ odyssey
University of Cambridge researchers are part of a collaborative project tasked with developing models, infrastructure and machine learning algorithms... Read More
-
Abcam antibody aces and CRUK target new cancer therapies
Cancer Research UK and Abcam plc in Cambridge have forged a potentially game-changing partnership designed to generate new therapies to fight the... Read More
-
Lynparza approved in the EU for pancreatic cancer
AstraZeneca and MSD Inc reveal that potential blockbuster drug Lynparza (olaparib) – developed from Cambridge UK Intellectual Property – has been... Read More